Skip to main content

Table 1 Healthy individuals and rectal cancer (RC) patients’ characteristics

From: Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX

  Number of individuals Mean/median age Pathologic stage (UICC) 1/2/3/4 (%) Chemotherapy 5-FU/5-Fu + Oxa/Irinotecan/5-FU + Irinotecan (%) Lymph node metastasis yes/no (%) Total RT dose (Gy)
Healthy individuals 59 56.0/58.5     
Patients 136 63.7/66.0 0/8.1/75.7/16.2 25.7/64.5/2.9/3.7 89.5/10.5 50.4